Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + metformin vs metformin alone in type 2 diabetes mellitus with dyslipidemia on statin
2006-000924-15Phase 3Completed
- Sponsor
- Fournier
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and dyslipidemia comparing Fenofibrate + metformin fixed combination with Metformin alone (2 arms). Primary endpoints: Percentage change in triglycerides and Percentage change in HDL cholesterol. Started Jun 2006; status: completed.
02
Drugs
fenofibratemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on 2006-000924-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000924-15.